Rapid regression of microsatellite instability-high/programmed cell death ligand 1-negative recurrent endometrial carcinoma by immune checkpoint blockade with pembrolizumab: A case report and literature review
Sign Up to like & getrecommendations! Published in 2020 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2020.100553
Abstract: Highlights • Effective treatment options for recurrent endometrial carcinomas are limited.• Immune checkpoint inhibitor is a recent progress in cancer immunotherapy.• Reports on recurrent endometrial carcinomas managed by pembrolizumab are limited. read more here.
Keywords: immune checkpoint; regression microsatellite; recurrent endometrial; pembrolizumab ... See more keywords